1. Home
  2. Insights
  3. Federal Register

(N)Grant of Interim Extension of the Term of U.S. Patent No. 7,319,099; Bitopertin (GlyT1 inhibitor) Oral Tablets

Notice, published December 10, 2025. Notice of interim patent term extension.

Summary from the Federal Register

The United States Patent and Trademark Office has issued a certificate under 35 U.S.C. 156(d)(5) for a one-year interim extension of the term of U.S. Patent No. 7,319,099 ('099 patent).